These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27264220)

  • 1. Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial.
    Blumenthal JA; Feger BJ; Smith PJ; Watkins LL; Jiang W; Davidson J; Hoffman BM; Ashworth M; Mabe SK; Babyak MA; Kraus WE; Hinderliter A; Sherwood A
    Am Heart J; 2016 Jun; 176():53-62. PubMed ID: 27264220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease: The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical Trial.
    Blumenthal JA; Smith PJ; Jiang W; Hinderliter A; Watkins LL; Hoffman BM; Kraus WE; Liao L; Davidson J; Sherwood A
    JAMA Psychiatry; 2021 Nov; 78(11):1270-1278. PubMed ID: 34406354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial.
    Blumenthal JA; Smith PJ; Jiang W; Hinderliter A; Watkins LL; Hoffman BM; Kraus WE; Mabe S; Liao L; Davidson J; Sherwood A
    Am Heart J; 2022 Sep; 251():91-100. PubMed ID: 35609671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial.
    Blumenthal JA; Smith PJ; Jiang W; Hinderliter A; Watkins LL; Hoffman BM; Kraus WE; Mabe S; Liao L; Davidson J; Sherwood A
    J Cardiovasc Dev Dis; 2022 Sep; 9(10):. PubMed ID: 36286272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.
    Kim JM; Bae KY; Stewart R; Jung BO; Kang HJ; Kim SW; Shin IS; Hong YJ; Kim JH; Shin HY; Kang G; Ahn Y; Kim JK; Jeong MH; Yoon JS
    J Clin Psychiatry; 2015 Jan; 76(1):62-8. PubMed ID: 25375836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial.
    Sherwood A; Blumenthal JA; Smith PJ; Watkins LL; Hoffman BM; Hinderliter AL
    Psychosom Med; 2016 Jun; 78(5):602-9. PubMed ID: 26867076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological interventions for coronary heart disease.
    Richards SH; Anderson L; Jenkinson CE; Whalley B; Rees K; Davies P; Bennett P; Liu Z; West R; Thompson DR; Taylor RS
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002902. PubMed ID: 28452408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial.
    Jiang W; Velazquez EJ; Kuchibhatla M; Samad Z; Boyle SH; Kuhn C; Becker RC; Ortel TL; Williams RB; Rogers JG; O'Connor C
    JAMA; 2013 May; 309(20):2139-49. PubMed ID: 23695483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial.
    Jiang W; Velazquez EJ; Samad Z; Kuchibhatla M; Martsberger C; Rogers J; Williams R; Kuhn C; Ortel TL; Becker RC; Pristera N; Krishnan R; O'Connor CM
    Am Heart J; 2012 Jan; 163(1):20-6. PubMed ID: 22172432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S; Osatuke K; Aslam M; Kasckow J
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
    Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
    Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.
    Blumenthal JA; Sherwood A; Rogers SD; Babyak MA; Doraiswamy PM; Watkins L; Hoffman BM; O'Connell C; Johnson JJ; Patidar SM; Waugh R; Hinderliter A
    Clin Trials; 2007; 4(5):548-59. PubMed ID: 17942470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.
    Davidson JR; Bose A; Korotzer A; Zheng H
    Depress Anxiety; 2004; 19(4):234-40. PubMed ID: 15274172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study.
    Blumenthal JA; Sherwood A; Babyak MA; Watkins LL; Smith PJ; Hoffman BM; O'Hayer CV; Mabe S; Johnson J; Doraiswamy PM; Jiang W; Schocken DD; Hinderliter AL
    J Am Coll Cardiol; 2012 Sep; 60(12):1053-63. PubMed ID: 22858387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.
    Faria V; Gingnell M; Hoppe JM; Hjorth O; Alaie I; Frick A; Hultberg S; Wahlstedt K; Engman J; Månsson KNT; Carlbring P; Andersson G; Reis M; Larsson EM; Fredrikson M; Furmark T
    EBioMedicine; 2017 Oct; 24():179-188. PubMed ID: 29033138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-based cardiac rehabilitation for coronary heart disease.
    Dibben G; Faulkner J; Oldridge N; Rees K; Thompson DR; Zwisler AD; Taylor RS
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001800. PubMed ID: 34741536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ; Gergel I; Bose A
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Acute Exercise on Anxiety Ratings in Patients With Coronary Heart Disease and Elevated Anxiety.
    Malian HM; Smith PJ; Hoffman B; Jiang W; Ammerman K; Kraus WE; Hinderliter A; Sherwood A; Blumenthal JA
    J Cardiopulm Rehabil Prev; 2021 Jul; 41(4):277-281. PubMed ID: 34158457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.